Table 1.
Characteristics of ASD patients
| Characteristics | Value |
|---|---|
| Number, n | 47 |
| Age (years), median (IQR) | 40 (28–56) |
| Age at onset (years), median (IQR) | 39 (27–56) |
| Male, n (%) | 15 (31.9) |
| WBC (μL), median (IQR) | 9900 (7700–16,150) |
| Ferritin (ng/mL), median (IQR) | 1159 (310–3887) |
| CRP (mg/dL), median (IQR) | 6.8 (2.9–10.9) |
| ALT (IU/L), median (IQR) | 33 (20–68) |
| Pouchot’s score, median (IQR) | 3 (2–5) |
| PSL (mg/day), median (IQR) | 40 (40–60) |
| Corticosteroid pulse therapy, n (%) | 24 (54.5) |
| Immunosuppressant, n (%) | 33 (75.0) |
| Biologics, n (%) | 6 (15.6) |
| Polycyclic systemic type, n (%) | 29 (64.4) |
| Monocyclic systemic type, n (%) | 15 (33.3) |
| Chronic arthritis type, n (%) | 6 (15.6) |